Want to see DE:93M1 full AI Analyst Report?
93M1 Stock Chart & Stats
€25.10
-€0.40(-1.66%)
At close: 4:00 PM EDT
€25.10
-€0.40(-1.66%)
Day’s Range― - ―
52-Week Range€17.45 - €29.70
Previous CloseN/A
Volume1.24K
Average Volume (3M)1.59K
Market Cap
€122.02M
Enterprise Value€141.07M
Total Cash (Recent Filing)€2.82M
Total Debt (Recent Filing)€15.37M
Price to Earnings (P/E)1.1
Beta0.66
Next Earnings
Nov 25, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield17.54%
Share Statistics
EPS (TTM)25.01
Shares Outstanding4,281,384
10 Day Avg. Volume1,440
30 Day Avg. Volume1,586
Financial Highlights & Ratios
PEG Ratio-0.38
Price to Book (P/B)0.39
Price to Sales (P/S)0.26
P/FCF Ratio765.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)8.7
Revenue Forecast (FY)€41.20M
Bulls Say, Bears Say
Bulls Say
Low LeverageVery low debt relative to equity gives MPH substantial financial flexibility and reduces interest and refinancing pressure. This conservative structure can help the holding company withstand valuation swings in its healthcare investments while preserving capacity for future portfolio decisions.
Restored ProfitabilityA return to sustained profitability since 2022 indicates that the portfolio and holding structure have regained earnings capacity after earlier losses. Continued positive results provide a stronger base for retaining capital, supporting distributions, and funding ongoing investment activity.
Healthcare Portfolio ExposureExposure to both pharmaceuticals and healthcare services gives MPH a business model tied to established healthcare activities rather than a single operating product. Managing several healthcare interests can provide a durable platform for portfolio development over the medium term.
Bears Say
Erratic RevenueHighly inconsistent revenue makes it difficult to assess the underlying earnings trajectory and weakens confidence in repeatable operating performance. For a holding company, large swings may also reflect changing investment outcomes, making medium-term planning and forecasting less reliable.
Weak Cash ConversionUnreliable operating cash generation limits the company’s ability to self-fund investments and distributions from recurring internal resources. The renewed 2025 decline, after improvement in 2024, also suggests that reported profitability may not consistently translate into available cash.
Declining Equity BaseA declining equity base can reduce the financial cushion supporting the investment portfolio and may constrain future flexibility if the trend continues. The stated pressure from distributions, valuation changes, or other non-operating movements also adds uncertainty to capital retention.
93M1 FAQ
What was MPH Health Care AG’s price range in the past 12 months?
MPH Health Care AG lowest stock price was €17.45 and its highest was €29.70 in the past 12 months.
What is MPH Health Care AG’s market cap?
MPH Health Care AG’s market cap is €122.02M.
When is MPH Health Care AG’s upcoming earnings report date?
MPH Health Care AG’s upcoming earnings report date is Nov 25, 2026 which is in 35 days.
How were MPH Health Care AG’s earnings last quarter?
MPH Health Care AG released its earnings results on Sep 16, 2026. The company reported €1.169 earnings per share for the quarter.
Is MPH Health Care AG overvalued?
According to Wall Street analysts MPH Health Care AG’s price is currently Overvalued.
Does MPH Health Care AG pay dividends?
MPH Health Care AG pays a Annually dividend of €5 which represents an annual dividend yield of 17.54%. See more information on MPH Health Care AG dividends here
What is MPH Health Care AG’s EPS estimate?
MPH Health Care AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MPH Health Care AG have?
MPH Health Care AG has 4,281,384 shares outstanding.
What happened to MPH Health Care AG’s price movement after its last earnings report?
MPH Health Care AG reported an EPS of €1.169 in its last earnings report. Following the earnings report the stock price went down -0.733%.
Which hedge fund is a major shareholder of MPH Health Care AG?
Currently, no hedge funds are holding shares in DE:93M1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
MPH Health Care AG Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
87.92%
12-Months-Change
Fundamentals
Return on Equity
43.53%
Trailing 12-Months
Asset Growth
21.86%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
MPH Health Care AG
MPH Health Care AG is a German-based investment firm with a primary focus on the healthcare sector. The company's portfolio includes the production and distribution of medicinal products designed to treat serious illnesses like cancer, HIV, and various other chronic conditions. Beyond pharmaceuticals, it also delivers medical aesthetic treatments, develops and markets a diverse array of pharmaceutical and medical items, and furnishes related services and specialized medical devices for use in aesthetic surgery and cosmetic dermatology. Furthermore, its operations extend to supplying cytostatic solutions and involvement in real estate ventures. Established in Berlin in 2008, the company adopted its current name, MPH Health Care AG, in 2017, having previously been known as MPH Mittelständische Pharma Holding AG. It functions as a subsidiary of Magnum AG.